Major Surgical or Invasive Procedure: 1) US guided paracentesis 2) right IJ 3) ERCP   History of Present Illness: Ms. [**Known lastname 18323**] is a 41 year old female with history of metastatic melanoma status post recent spinal fusion surgery for multiple metastatic spinal lesions, recently discharged from the surgical service on [**2140-8-31**], who was transferred from an OSH today with severe abdominal pain.
On [**8-31**] (the day of discharge), at around midnight she was awoken from sleep by the sudden onset of LLQ abdominal pain which she cannot quantify or qualify, but states that it felt as though her abdomen was bursting open.
She recived NS x 1L, dilaudid 3 mg IV, zofran 4 mg IV, and 4.5 mg IV zosyn.
She was then transferred to the [**Hospital1 18**] ED for further management.
She received 8 mg IV dilaudid, promethiazine, lorazepam 2mg IV, and zosyn 4.5 gm IV x 1.
She was evaluated by general surgery who thought that the patient required ICU monitoring but did not see her as a surgical patient.
She was thus transferred to the [**Hospital Unit Name 153**] for closer monitoring, pain control and fluid resuscitation.
Past Medical History: Oncologic history: 1) Melanoma:  s/p wide local excision of melanoma of the left groin on 02/[**2136**].
s/p re-excision on [**2136-3-23**] - no residual melanoma [**4-18**] LN negative.
2) Reflux 3) otosclerosis 4) Anorexia  Social History: She is single, living with her mother.
She was living in [**State 108**], but came to [**Location (un) 86**] recently for further treatment of her melanoma.
HEENT: Dry mucous membranes, anicteric sclerae, NGT in place.
spinal canal cannot be assessed properly due to artifact from metal fusion device.
Interval laminectomies and spinal fusion hardware spanning the region of the previously identified pathological fracture of L4.
Pt was made NPO and given IVF.
Pt's abdominal pain gradually improved and amylase and lipase normalized.
## Abdominal distention - pt developed increasing abdominal distension thought to be secondary to narctoics for pain control and bed rest.
Patient was given IV lasix with good diuresis and underwent US guided paracentesis with drainage of 1.4 liters of bloody ascitic fluid.
Initially she was started on levofloxacin, but this was discontinued due to abscence of symptoms and she remained without any cough or clinical worsening following this.
Pt's prior spine surgeyr sites were monitored and no evidence of infection was found.
Urine grew yeast, foley was removed and patient was encouraged to ambulate.
Patient was restarted on empiric coverage with IV levoquin.
Patient's foley was discontinued secondary to yeast which grew on urine cultures x2.
Some R neck fullness initially noted, neck U/S with heterogeneous masses consistent with metastases.
Patient was intially followed in preparation for initiating biologics however patient was not interested in rehab in order to regain strength prior to treatment.
Plan for biologics were held off until patient was more stable.
## F/E/N:  pt initially given IVF with dextrose.
Central line was placed and TPN initiated.
Following pancreatic stenting, pt started taking clear sips and diet was advanced slowly as tolerated.
Triple lumen was placed and was receiving TPN due to insufficient PO.
## Hypertension: Patient was started on PO antihypertensives.
Labetalol was titrated up and the clonidine patches were transitioned off.
## s/p spine surgery - Continued to monitor for possible infection.
Pain was not well controlled on fentanyl patches and patient was resumed on original dilaudid PCA dosing from [**9-13**] prior to conversion.
Fentanyl 100 mcg/hr Patch 72HR 2.
Lorazepam 0.5 mg Tablet 3.
Oxycodone-Acetaminophen 5-325 mg 4.
Pantoprazole Sodium 40 mg Tablet, Delayed Release 5.
Cyclobenzaprine 10 mg Tablet 6.
Zolpidem Tartrate 5 mg Tablet 7.
Nystatin 100,000 unit/mL Suspension 8.
Docusate Sodium 100 mg Capsule 9.
Senna 8.6 mg Tablet 10.
Bisacodyl 10 mg Suppository  Discharge Disposition: Expired  Discharge Diagnosis: metastatic melanoma  Discharge Condition: deceased   Completed by:[**2140-10-8**
